Viewing Study NCT00484432


Ignite Creation Date: 2025-12-24 @ 9:25 PM
Ignite Modification Date: 2026-01-01 @ 8:44 AM
Study NCT ID: NCT00484432
Status: COMPLETED
Last Update Posted: 2018-09-27
First Post: 2007-06-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Advanced or Metastatic Ovarian Cancer
Sponsor: AGC Biologics S.p.A.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module